article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt. Impending change affords an opportunity for innovation.